Creative Biolabs supports microbiome innovators who need decision-grade Enterococcus lactis data. We help biotech, food-tech, and animal health R&D teams translate a strain from sample to validated candidate—building confidence in identity, safety, functionality, and manufacturability with reproducible methods and clear documentation.
R&D groups rely on Creative Biolabs for reproducible E. lactis strain data across development milestones.
E. lactis is a lactic acid bacterium originally described from raw milk cheeses, and it is now being explored across diverse microbiome and fermentation pipelines. Yet, “E. lactis” is not a single performance profile—strain-level variation can reshape acid/bile tolerance, bacteriocin production, adhesion phenotypes, and antibiotic susceptibility patterns.
For teams working under tight timelines, the real risk is not a lack of experiments—it is non-comparable results produced by inconsistent cultivation, incomplete identity confirmation, or insufficient safety qualification. A purpose-built CRO workflow reduces ambiguity early, so downstream formulation, scale-up, and functional screening are driven by stable, traceable strain attributes.
Creative Biolabs isolates E. lactis from complex matrices (fecal, food, environmental, animal) using selective workflows that preserve viability and minimize overgrowth bias. Screening prioritizes colony morphology, growth kinetics, and stability under oxygen, acid, bile, and osmotic stress to shortlist E. lactis candidates that match your intended research conditions.
Species-level calls for E. lactis require orthogonal confirmation. We combine molecular identification approaches to distinguish E. lactis from closely related enterococci, then lock traceability with strain records and versioned identifiers. This reduces downstream rework caused by misclassification and ensures your phenotype data stays tied to the correct E. lactis organism.
A defensible E. lactis profile includes biosafety-relevant phenotyping aligned with your study goals. We evaluate growth behavior, hemolysis patterns (when applicable), and enzymatic/toxin-adjacent signals, and we align deliverables to non-clinical R&D expectations. Where appropriate, evidence frameworks used for E. lactis strains in regulated feed contexts help guide risk-language and documentation style.
Because antibiotic susceptibility can vary by E. lactis strain, standardized AST is essential for comparability and risk interpretation. We generate repeatable susceptibility profiles and relate results to strain selection decisions—especially when your pipeline requires robust documentation of E. lactis resistance phenotypes across passages or production-like conditions.
We translate E. lactis biology into fit-for-purpose functional readouts, such as inhibition assays against relevant indicator organisms and host-interface models tailored to your research question. Literature examples show that certain E. lactis strains can inhibit L. monocytogenes and other bacteria, and can generate measurable signals in cell-based assays—effects that must be verified under your exact protocol constraints.
To move E. lactis from bench to production-relevant material, we optimize upstream parameters (media, pH strategy, temperature, agitation, oxygen exposure) while tracking critical quality attributes such as growth rate, biomass yield, and functional marker retention. The goal is not just scale—it is phenotype continuity of your E. lactis strain across fermentation conditions.
E. lactis performance often changes after concentration, stabilization, or storage. We evaluate formulation-relevant stresses (freeze/thaw, desiccation, excipient compatibility) and measure post-process viability and functional retention. This keeps E. lactis readouts honest—reflecting the material format you will actually test in later studies.
When your program requires improved robustness, Creative Biolabs can support E. lactis optimization strategies that target stability, productivity, or functional output while preserving identity and traceability. Engineering is paired with verification assays so that any “improvement” is quantified and does not introduce hidden tradeoffs in E. lactis safety signals or manufacturability.
Define your E. lactis endpoint, matrix constraints, and evidence level for go/no-go decisions.
Recover E. lactis using selective conditions that maintain viability and reduce competitive loss.
Verify E. lactis with orthogonal methods and establish traceable strain documentation.
Profile E. lactis biosafety indicators and antibiotic susceptibility with standardized, comparable protocols.
Quantify E. lactis performance in targeted assays aligned to your intended research scenario.
Deliver decision-ready E. lactis datasets with recommendations for scale-up or refinement.
Decisions rely on verified E. lactis identity, not genus-level assumptions.
E. lactis data stays consistent across batches, passages, and study phases.
Clear E. lactis records support internal review and partner due diligence.
Assays are selected to answer E. lactis program questions directly.
E. lactis studies anticipate fermentation and formulation realities early.
E. lactis safety signals are mapped upfront to avoid late-stage surprises.
Specific E. lactis strains have been reported to tolerate acid/bile conditions, adhere to epithelial models, and inhibit bacterial indicators (including L. monocytogenes). These properties make E. lactis a practical target for mechanistic microbiome studies focused on colonization and competitive interactions.
As a species described from raw milk cheeses, E. lactis is relevant to starter-adjacent research and safety-by-design fermentation workflows. Certain E. lactis isolates produce bacteriocins with antilisterial activity, supporting research on natural preservation strategies and process-compatible antimicrobials.
E. lactis has been evaluated in feed-related contexts, including EFSA-reviewed strain documentation frameworks and controlled feeding studies. A 2025 quail study reported performance and antioxidant-related readouts with E. lactis TRM58998, and aquaculture research has profiled E. lactis A1 for functional properties in fish models.
Beyond food and gut environments, E. lactis is being explored in niche ecosystems, including honeybee-associated microbiology where E. lactis GL3 was genomically and phenotypically characterized for antimicrobial activity against Paenibacillus larvae. These directions motivate strain scouting, metabolite profiling, and stability testing in non-traditional hosts.
The table below lists available E. lactis strains from different sources to support diverse research needs.
| Product Name | Catalog No. | Target | Product Overview | Size | Price |
|---|---|---|---|---|---|
| Enterococcus lactis; piglet | LBST-103FG | Enterococcus | Enterococcus lactis is a microaerophile, mesophilic, Gram-positive bacterium that was isolated from excrement of weaned piglets. | — | Inquiry |
| Enterococcus lactis | LBST-104FG | Enterococcus | Enterococcus lactis is a microaerophile, mesophilic, Gram-positive bacterium that was isolated from feces of tumor patients. | — | Inquiry |
| Enterococcus lactis; 20421 | LBST-105FG | Enterococcus | Enterococcus lactis is a microaerophile, mesophilic, Gram-positive bacterium that was isolated from Yoghurt. | 200 µg | $1,156.00 |
| Enterococcus lactis; 2007-0-1 | LBST-106FG | Enterococcus | Enterococcus lactis is a microaerophile, mesophilic, Gram-positive bacterium that was isolated from Yoghurt. | 200 µg | $1,156.00 |
| Enterococcus lactis; BR-1-16 | LBST-107FG | Enterococcus | Enterococcus lactis is a microaerophile, mesophilic, Gram-positive bacterium that was isolated from Vinegar. | 200 µg | $1,156.00 |
We use layered identification, not a single marker. Species calls are supported by orthogonal molecular confirmation and traceable strain documentation, reducing mislabeling risk and keeping all E. lactis phenotype data linked to the correct organism.
Yes. We align indicator organisms and assay conditions to your context and verify reproducibility across batches. Published work demonstrates that some E. lactis strains inhibit Listeria monocytogenes and other bacteria, supporting targeted screening strategies.
E. lactis performance can shift after scale-up, concentration, and storage. Fermentation and formulation studies quantify viability and functional retention in the same material form you will test later—preventing “great in broth, weak in product-format” outcomes.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.